Brief: Nextcell Pharma Q2 2026 Operating Income SEK 3.0 Mln
27/08/2026 06:33
BRIEF-Nextcell Pharma Q2 2026 Operating Income SEK 3.0 Mln Aug 27 (Reuters) - NextCell Pharma AB NXTCL.ST:
Q2 2026 OPERATING INCOME SEK 3.0 MILLION
Q2 PROFIT/LOSS AFTER FINANCIAL ITEMS SEK -11.7 MILLION (-11.2)
Source text: ID:nWkr6F8gWC
Further company coverage: NXTCL.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on NextCell Pharma AB
See all newsBrief: NextCell Updates On Timing Of ProTrans-Young Results
Brief: Nextcell Pharma Q2 2026 Operating Income SEK 3.0 Mln
Brief: NextCell Pharma Q1 Operating Income At SEK 2.8 Million
Brief: Nextcell Pharma Q4 Operating Income SEK 1.8 Mln
Brief: Nextcell Pharma Says ProTrans Data Show Insulin Production Preservation